Evidence map›Paper›PMID 41736562›Full record

ArticleDevelopment (Cambridge, England)2026

A robust cis-regulatory network ensures Otx2 expression during retinal development.

Ian J Purvis, Omar E Ochoa Olmos, Ko Uoon Park, Michael L Kaufman, Charles M Henry, Chris Schaaf, Olivia J Clise, Corey D Tesdahl, Ami Haas, Joseph A Brzezinski

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ian J PurvisDepartment of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.ORCID 0000-0001-6960-6324
Omar E Ochoa OlmosDepartment of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.ORCID 0000-0003-2931-3062
Ko Uoon ParkDepartment of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.ORCID 0000-0002-8254-5826
Michael L KaufmanDepartment of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.ORCID 0000-0003-2441-5836
Charles M HenryDepartment of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.ORCID 0009-0003-7143-6055
Chris SchaafDepartment of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.ORCID 0000-0001-7618-1547
Olivia J CliseDepartment of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Corey D TesdahlDepartment of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.ORCID 0000-0002-9572-2123
Ami HaasDepartment of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.ORCID 0000-0001-9815-8954
Joseph A BrzezinskiDepartment of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.ORCID 0000-0001-5854-0315

Funding

Mechanisms of cell fate specification and competence regulation in photoreceptorsR01EY024272 · NEI · UNIVERSITY OF COLORADO DENVER · PI Joseph A Brzezinski · 2014 to 2026
$5.3M
In The Loop: Investigating Enhancer-Mediated Regulation of OTX2 During Retinal DevelopmentF31EY034794 · NEI · UNIVERSITY OF COLORADO DENVER · PI PURVIS, IAN J · 2023 to 2025
$114k
Anschutz Medical Campus, University of ColoradoGates InstituteNEI NIH HHS F31 EY034794NEI NIH HHS R01 EY024272NIH HHS F31-EY034794NIH HHS F31EY034794NIH HHS R01-EY024272Research to Prevent BlindnessUniversity of Colorado
6 · The paper itself

Abstract

The transcription factor Otx2 is essential for photoreceptor and bipolar cell formation during retinal development. Otx2 expression is complex and underlies multiple cell fate decisions during development. To understand how Otx2 expression is regulated, we explored the activity and function of three of its enhancers (DHS2, DHS4 and DHS15). Enhancer reporter assays and lineage tracing show that DHS4 initiates Otx2 expression while DHS2 and DHS15 maintain expression in photoreceptors. Matched CRISPR/Cas9 and CRISPR interference systems were used to mutate or epigenetically silence enhancers, respectively. CRISPR reduced OTX2 expression acutely, but failed to significantly alter cell fate choice over the long term. In contrast, CRISPR interference of these enhancers caused permanent OTX2 loss and corresponding cell fate changes. While these data suggest that each enhancer is needed for normal Otx2 expression, it also highlights that the enhancers can interact and substitute for each other during development. This cis-regulatory element flexibility likely promotes Otx2 expression robustness. Such robustness may enable complex genes, like Otx2, to resist environmental stressors and regulatory disruptions to promote reproducible developmental outcomes.

Indexed as

Gene Expression Regulation, DevelopmentalGene Regulatory NetworksOtx Transcription FactorsRetinaAnimalsCRISPR-Cas SystemsEnhancer Elements, GeneticMiceOtx2 protein, mouseOtx Transcription FactorsBipolar cellsCell fate specificationCRISPRiEnhancersMouseOtx2PhotoreceptorsPromotersRetinal development

Identifiers

PMID41736562
PMCPMC13495790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.